CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Laboratorios Hipra against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing ThemBOEHRINGER INGELHEIM ANIMAL HEALTH USAMar 4, 2021
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIM ANIMAL HEALTH USAFeb 24, 2021
Use Of A Pcv2 Immunogenic Composition For Lessening Clinical Symptoms In PigsBOEHRINGER INGELHEIM ANIMAL HEALTH USASep 15, 2020
Vaccine Against Porcine Circo Virus Type 2INTERVETJul 10, 2020
Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIM ANIMAL HEALTH USAJan 8, 2020
Single Dose Anti-Pcv2 Pig VaccineBOEHRINGER INGELHEIM ANIMAL HEALTH USANov 20, 2019
Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such CompositionsBOEHRINGER INGELHEIM ANIMAL HEALTH USAOct 24, 2018

Top competitors of Laboratorios Hipra

List of top competitors of Laboratorios Hipra based on patent oppositions.